Scot Frazier Rogers
Known title: Chief Administrative OfficerCIK: 0001588334
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
RBC raises F5 price target to $525 amid software sector pullback. RBC Capital raised its price target for F5 to $525 while maintaining an Outperform rating. This action occurred as software stocks faced broader pressure from Middle East tensions and inflation concerns. The stock is currently trading near its 52-week high, with an average analyst target of $437.80.
Transaction History
| TDC | ▼ Sell | Tax Withholding | 13,247 | $445K | 6/15/2026 | View on chart |
| TDC | ▼ Sell | Tax Withholding | 10,266 | $345K | 6/15/2026 | View on chart |
| TDC | ▲ Buy | Grant | 53,630 | $0 | 3/1/2026 | View on chart |
| TDC | ▲ Buy | Grant | 31,711 | $0 | 2/11/2026 | View on chart |
| TDC | ▼ Sell | Tax Withholding | 4,813 | $182K | 2/11/2026 | View on chart |
| TDC | ▲ Buy | Grant | 69,694 | $0 | 6/13/2025 | View on chart |
| TDC | ▲ Buy | Grant | 89,928 | $0 | 6/13/2025 | View on chart |
| FFIV | ▼ Sell | Open Market | 3,486 | $1.0M | 2/26/2025 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 2,093 | $0 | 2/1/2025 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 846 | $251K | 2/1/2025 | View on chart |
| FFIV | ▼ Sell | Open Market | 1,061 | $246K | 11/4/2024 | View on chart |
| FFIV | ▼ Sell | Open Market | 2,398 | $558K | 11/4/2024 | View on chart |
| FFIV | ▼ Sell | Open Market | 1,076 | $248K | 11/4/2024 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 2,009 | $0 | 11/1/2024 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 4,893 | $1.1M | 11/1/2024 | View on chart |
| FFIV | ▲ Buy | Grant | 10,439 | $0 | 10/31/2024 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 465 | $0 | 8/1/2024 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 750 | $0 | 8/1/2024 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 796 | $0 | 8/1/2024 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 790 | $0 | 8/1/2024 | View on chart |
| FFIV | ▼ Sell | Open Market | 473 | $95K | 7/30/2024 | View on chart |
| FFIV | ▼ Sell | Open Market | 947 | $189K | 7/30/2024 | View on chart |
| FFIV | ▼ Sell | Open Market | 3,315 | $558K | 6/5/2024 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 465 | $0 | 5/1/2024 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 750 | $0 | 5/1/2024 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 795 | $0 | 5/1/2024 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 789 | $0 | 5/1/2024 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 2,009 | $0 | 2/1/2024 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 823 | $0 | 2/1/2024 | View on chart |
| FFIV | ▼ Sell | Open Market | 1,500 | $263K | 12/12/2023 | View on chart |
| FFIV | ▼ Sell | Open Market | 2,000 | $303K | 11/2/2023 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 1,978 | $0 | 11/1/2023 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 3,713 | $0 | 11/1/2023 | View on chart |
| FFIV | ▲ Buy | Grant | 7,471 | $0 | 10/31/2023 | View on chart |
| FFIV | ▼ Sell | Open Market | 1,000 | $160K | 8/9/2023 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 1,976 | $0 | 8/1/2023 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 775 | $0 | 8/1/2023 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 1,977 | $0 | 5/1/2023 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 776 | $0 | 5/1/2023 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 1,976 | $0 | 2/1/2023 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 815 | $0 | 2/1/2023 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 1,912 | $0 | 11/1/2022 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 3,495 | $0 | 11/1/2022 | View on chart |
| FFIV | ▲ Buy | Grant | 6,984 | $0 | 10/31/2022 | View on chart |
| FFIV | ▼ Sell | Open Market | 878 | $145K | 8/3/2022 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 1,911 | $0 | 8/1/2022 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 750 | $0 | 8/1/2022 | View on chart |
| FFIV | ▼ Sell | Open Market | 879 | $151K | 5/3/2022 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 1,912 | $0 | 5/1/2022 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 750 | $0 | 5/1/2022 | View on chart |
| FFIV | ▼ Sell | Open Market | 852 | $170K | 2/3/2022 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 1,910 | $0 | 2/1/2022 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 776 | $0 | 2/1/2022 | View on chart |
| FFIV | ▼ Sell | Open Market | 1,919 | $422K | 11/3/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 1,200 | $262K | 11/3/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 1,214 | $268K | 11/3/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 3,442 | $763K | 11/3/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 200 | $44K | 11/3/2021 | View on chart |
| FFIV | ▲ Buy | Option Exercise | 2,411 | $0 | 11/1/2021 | View on chart |
| FFIV | ▼ Sell | Tax Withholding | 5,158 | $0 | 11/1/2021 | View on chart |
| FFIV | ▲ Buy | Grant | 10,722 | $0 | 10/29/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 800 | $174K | 10/27/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 469 | $101K | 10/27/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 1,131 | $248K | 10/27/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 500 | $108K | 10/27/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 400 | $88K | 10/27/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 500 | $111K | 10/27/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 829 | $179K | 10/27/2021 | View on chart |
| FFIV | ▼ Sell | Open Market | 200 | $45K | 10/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Teradata Reports New Enterprise AI Deals in Healthcare
Teradata announced new enterprise AI customer engagements in the healthcare and life sciences sectors. This development highlights the company's continued focus on artificial intelligence applications within specialized industries. The news coincides with a period of strong performance for several technology peers, including Palantir and Snowflake, suggesting a broader positive sentiment in the sector.
Teradata Reports New Enterprise AI Deals in Healthcare. Teradata announced new enterprise AI customer engagements in the healthcare and life sciences sectors. This development highlights the company's continued focus on artificial intelligence applications within specialized industries. The news coincides with a period of strong performance for several technology peers, including Palantir and Snowflake, suggesting a broader positive sentiment in the sector.